Methyl 2-(6-(3-morpholinophenoxy)-4-oxo-7-(4-(4-(trifluoromethyl)phenoxy)butanamido)quinazolin-3(4H)-yl)acetate

ID: ALA4763678

PubChem CID: 162661992

Max Phase: Preclinical

Molecular Formula: C32H31F3N4O7

Molecular Weight: 640.62

Molecule Type: Unknown

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  COC(=O)Cn1cnc2cc(NC(=O)CCCOc3ccc(C(F)(F)F)cc3)c(Oc3cccc(N4CCOCC4)c3)cc2c1=O

Standard InChI:  InChI=1S/C32H31F3N4O7/c1-43-30(41)19-39-20-36-26-18-27(37-29(40)6-3-13-45-23-9-7-21(8-10-23)32(33,34)35)28(17-25(26)31(39)42)46-24-5-2-4-22(16-24)38-11-14-44-15-12-38/h2,4-5,7-10,16-18,20H,3,6,11-15,19H2,1H3,(H,37,40)

Standard InChI Key:  QEXLOMXRNXSROR-UHFFFAOYSA-N

Molfile:  

 
     RDKit          2D

 46 50  0  0  0  0  0  0  0  0999 V2000
    3.9339  -17.6209    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.2242  -17.2023    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.5084  -17.6108    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.5040  -18.4367    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.2215  -18.8524    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.9345  -18.4415    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.7912  -18.8485    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.0933  -18.3758    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
    1.7929  -19.7706    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
    1.0738  -19.1537    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
    8.9399  -16.4037    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.9388  -17.2310    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.6536  -17.6439    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.6518  -15.9909    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.3671  -16.4000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.3705  -17.2331    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.0897  -17.6444    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   11.8101  -17.2271    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.8067  -16.3941    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   11.0829  -15.9783    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.0783  -15.1533    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   12.5198  -15.9794    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.2206  -17.6411    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    8.2252  -15.9907    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    7.5081  -17.2252    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.2254  -15.1657    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.2356  -16.3896    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.9395  -14.7577    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.9402  -13.9336    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.2253  -13.5200    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.5083  -13.9367    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.5113  -14.7596    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.5120  -16.4003    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    6.7917  -17.6344    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.2381  -17.2146    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   13.9487  -15.9749    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   14.6645  -16.3852    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.0793  -17.2186    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.3628  -17.6276    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.6504  -17.2118    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    6.7937  -13.5246    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    6.7975  -12.6987    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.0870  -12.2867    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.3704  -12.6961    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    5.3689  -13.5220    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.0840  -13.9385    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  2  0
  6  1  1  0
  7  8  1  0
  7  9  1  0
  7 10  1  0
  4  7  1  0
 11 12  2  0
 12 13  1  0
 13 16  2  0
 15 14  2  0
 14 11  1  0
 15 16  1  0
 15 20  1  0
 16 17  1  0
 17 18  2  0
 18 19  1  0
 19 20  1  0
 20 21  2  0
 19 22  1  0
 12 23  1  0
 11 24  1  0
 23 25  1  0
 24 26  1  0
 22 27  1  0
 26 28  2  0
 28 29  1  0
 29 30  2  0
 30 31  1  0
 31 32  2  0
 32 26  1  0
 25 33  2  0
 25 34  1  0
 27 35  2  0
 27 36  1  0
 36 37  1  0
 34 38  1  0
 38 39  1  0
 39 40  1  0
 40  1  1  0
 31 41  1  0
 41 42  1  0
 41 46  1  0
 42 43  1  0
 43 44  1  0
 44 45  1  0
 45 46  1  0
M  END

Alternative Forms

  1. Parent:

    ALA4763678

    ---

Associated Targets(Human)

NOD1 Tchem Nucleotide-binding oligomerization domain-containing protein 1 (1322 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
NOD2 Tclin Nucleotide-binding oligomerization domain-containing protein 2 (1613 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 640.62Molecular Weight (Monoisotopic): 640.2145AlogP: 5.01#Rotatable Bonds: 11
Polar Surface Area: 121.22Molecular Species: NEUTRALHBA: 10HBD: 1
#RO5 Violations: 2HBA (Lipinski): 11HBD (Lipinski): 1#RO5 Violations (Lipinski): 3
CX Acidic pKa: 11.86CX Basic pKa: 4.24CX LogP: 4.12CX LogD: 4.12
Aromatic Rings: 4Heavy Atoms: 46QED Weighted: 0.18Np Likeness Score: -1.53

References

1. Ma Y,Yang J,Wei X,Pei Y,Ye J,Li X,Si G,Tian J,Dong Y,Liu G.  (2020)  Nonpeptidic quinazolinone derivatives as dual nucleotide-binding oligomerization domain-like receptor 1/2 antagonists for adjuvant cancer chemotherapy.,  207  [PMID:32920426] [10.1016/j.ejmech.2020.112723]

Source